<DOC>
	<DOCNO>NCT01273870</DOCNO>
	<brief_summary>The aim dialyzer evaluation compare performance characteristic haemocompatibility Baxter Xenium+ ( Polynephron ) , Fresenius FX Gambro Polyflux dialyzer</brief_summary>
	<brief_title>Blood Compatibility Characteristics Baxter Xenium+ , Fresenius FX Gambro Polyflux Dialyzers</brief_title>
	<detailed_description>The Xenium+ new high flux dialyzer make Polynephron membrane design manufacture Nipro Company Japan . This dialyzer subject in-vitro testing , legally required biological safety test conduct CE-mark grant June 2010 . Xenium+ Polynephron membrane Xenium family dialyzer available commercially globally approximately three year . Clinical evaluation complete Polynephron membrane within last three year . The improvement Xenium+ line case make polypropylene . The aim dialyzer evaluation compare performance characteristic hemocompatibility Xenium+ ( Polynephron ) , Fresenius FX Gambro Polyflux dialyzer .</detailed_description>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<criteria>ESRD patient 18 year older Stable hemodialysis 3 month An average haematocrit value 30 % high last three 3 month Stable vascular access either fistula graft Stable anticoagulation regimen Stable erythropoiesisstimulating agent ( ESA ) regimen last three 3 month No active infection Able sign inform consent able participate study Medically stable Participation another study may interfere plan study Active infection Medical condition may interfere study ( cardiac , liver disease , hepatitis ) Female ( ) pregnant plan pregnant Problem allergy anticoagulation Central venous catheter</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>hemodialysis</keyword>
	<keyword>high-flux-dialyzer</keyword>
	<keyword>performance</keyword>
	<keyword>blood compatibility</keyword>
</DOC>